Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)

Market Cap	68.23B
Revenue (ttm)	272.42B
Net Income (ttm)	4.03B
Shares Out	3.70B
EPS (ttm)	1.08
PE Ratio	19.07
Forward PE	21.98
Dividend	0.41 (1.95%)
Ex-Dividend Date	Sep 24, 2024

Volume	11,909,900
Open	21.30
Previous Close	21.00
Day's Range	20.66 - 21.62
52-Week Range	15.36 - 23.20
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 30, 2025

About Shanghai Pharmaceuticals Holding

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, syste...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 48,164
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 601607

Financial Performance

In 2023, Shanghai Pharmaceuticals Holding's revenue was 260.30 billion, an increase of 12.21% compared to the previous year's 231.98 billion. Earnings were 3.77 billion, a decrease of -32.92%.